CompoAtlas

Prostate-Capsules

Natural health product licensed in Canada

Licence holder
Harena Maris Health Group Inc.
NPN or DIN-HM
80037995
Status
Inactive licence
Licence date
30 November 2012
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vaccinium macrocarpon

Source : Fruit

Extraction ratio : 35:1

Dry plant equivalent : 595 mg

17 mgNot calculated
Serenoa repens

Source : Fruit

Extraction ratio : 10:1

Dry plant equivalent : 1,000 mg

Potency : 85 % Fatty acids

100 mgNot calculated
Prunus africana

Source : Écorce (tige)

Extract : Extract Type TBA

Extraction ratio : 15:1

Dry plant equivalent : 90 mg

6 mgNot calculated
Urtica dioica

Source : Racine

Extraction ratio : 5:1

Dry plant equivalent : 500 mg

100 mgNot calculated
Agathosma betulina

Source : Racine

Extract : Extract Type TBA

Extraction ratio : 15:1

Dry plant equivalent : 375 mg

25 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Extrait de soie de maïs, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified1 Capsule2 days

Uses authorised in Canada

Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Provides antioxidants for the maintenance of good health. Used in herbal medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80037995

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line